# OraSure Submits CT/NG Molecular Self-Test and Colli-Pee™ Urine Collection Device for FDA Review
Canonical URL: https://biopharmsignal.com/news/OSUR/orasure-submits-ct-ng-molecular-self-test-and-colli-peetm-urine-collection-device-for-fda-review
Ticker: OSUR
Company: OraSure Technologies, Inc.
Source: OraSure Technologies, Inc.
Published: 2026-01-05 13:00 EST
Original Source URL: https://orasure.gcs-web.com
## Summary

BETHLEHEM, Pa., Jan. 05, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) (“OraSure” and “OTI”), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that it submitted two separate applications at the end of 2025 to the U.S.

## Article Body
BETHLEHEM, Pa., Jan. 05, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) (“OraSure” and “OTI”), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that it submitted two separate applications at the end of 2025 to the U.S.
## Recent Company News
- 2026-05-06 20:05 EST — [OraSure Announces First Quarter 2026 Financial Results](https://biopharmsignal.com/news/OSUR/orasure-announces-first-quarter-2026-financial-results) — Source: OraSure Technologies, Inc.
- 2026-04-22 20:10 EST — [OraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6th](https://biopharmsignal.com/news/OSUR/orasure-to-announce-first-quarter-2026-financial-results-and-host-earnings-call-on-may-6th) — Source: OraSure Technologies, Inc.
- 2026-04-17 00:10 EST — [OraSure Technologies Appoints John D. Bertrand to its Board of Directors](https://biopharmsignal.com/news/OSUR/orasure-technologies-appoints-john-d-bertrand-to-its-board-of-directors) — Source: OraSure Technologies, Inc.
- 2026-03-17 20:53 EST — [OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital](https://biopharmsignal.com/news/OSUR/orasure-highlights-significant-operational-progress-and-value-creation-initiatives-following-letter-from-altai-capital) — Source: OraSure Technologies, Inc.
- 2026-02-25 21:05 EST — [OraSure Announces Fourth Quarter 2025 Financial Results](https://biopharmsignal.com/news/OSUR/orasure-announces-fourth-quarter-2025-financial-results) — Source: OraSure Technologies, Inc.
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)